Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...
A head-to-head comparison of vascular closure devices defied expectations in the CHOICE-CLOSURE trial. For large-bore arterial access site closure after transfemoral transcatheter aortic valve ...
LAS VEGAS -- Bleeding complication risk after transcatheter aortic valve replacement (TAVR) isn't the same between two of the most commonly used femoral vascular closure devices, one study showed, ...
LAS VEGAS (MAY 21, 2019) - Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of ...
The plug-based Manta (Teleflex) device was associated with significantly more vascular complications than the suture-based ProGlide (Abbott Vascular) device following transfemoral transcatheter aortic ...
Use of a large-bore, plug-based vascular closure device (Manta; Teleflex) following transfemoral TAVI is associated with a higher risk of vascular complications when compared with an older ...
Abbott Park, IL - Abbott Laboratories announced the launch of the next-generation Perclose ® suture-mediated vessel closure system, Perclose ProGlide TM, featuring a polypropylene monofilament suture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results